Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren Combined With Losartan in IgA Nephropathy
NCT00922311Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Jul 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in IgA nephropathy (IgAN), sponsored by The University of Hong Kong. Started Jul 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00922311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922311.